N🟁N

Incyte to Report Second Quarter 2010 Financial Results and Provide Update on Drug Discovery & Development Programs on August 5

  //health-fitness.news-articles.net/content/2010/ .. -discovery-development-programs-on-august-5.html
  Published in Health and Fitness on Tuesday, July 20th 2010 at 13:25 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter 2010 financial results conference call for 8:30 a.m. ET on Thursday, August 5, 2010. The schedules for the press release and conference call are as follows:

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 354043.

The conference call will also be webcast live on CCBN and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. Incytea™s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].